Skip to content

Opening book details…

About this Medicine article

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers by Salama, J. K.; Haraf, D. J.; Stenson, K. M.; Blair, E. A.; Witt, M. E.; Williams, R.; Kunnavakkam, R.; Cohen, E. E. W.; Seiwert, T.; Vokes, E. E. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Salama, J. K.; Haraf, D. J.; Stenson, K. M.; Blair, E. A.; Witt, M. E.; Williams, R.; Kunnavakkam, R.; Cohen, E. E. W.; Seiwert, T.; Vokes, E. E.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Salama, J. K.; Haraf, D. J.; Stenson, K. M.; Blair, E. A.; Witt, M. E.; Williams, R.; Kunnavakkam, R.; Cohen, E. E. W.; Seiwert, T.; Vokes, E. E.

Browse all works by Salama, J. K.; Haraf, D. J.; Stenson, K. M.; Blair, E. A.; Witt, M. E.; Williams, R.; Kunnavakkam, R.; Cohen, E. E. W.; Seiwert, T.; Vokes, E. E.